BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

Med’s Industry

Medit and OraQ Announce Strategic Partnership to Advance AI-Driven Intelligence in Digital Dentistry

The partnership brings together Medit's open, global digital platform and OraQ's advanced AI technologies to create new pathways for innovation and connect...

November 13, 2025 | News

Thermo Fisher Wins 510(k) Nod for EXENT System to Advance Myeloma Diagnosis

First-of-its-kind, automated system delivers increased sensitivity, specific identification of disease markers and improved laboratory workflow to support ...

November 13, 2025 | News

MGI Tech, SAMRC and DSTI Launch Africa’s First DNBSEQ-T7 Sequencer and 110K Human Genome Program in South Africa

MGI Tech Co., Ltd., a company dedicated to developing core tools and technologies that drive innovation in life sciences, announced two historic milestones...

November 12, 2025 | News

SOPHiA GENETICS and Element Biosciences Partner to Merge Sequencing and AI Analytics for Precision Medicine

SOPHiA GENETICS (NASDAQ: SOPH), a global leader in AI-driven precision medicine, and Element Biosciences, Inc., a biology company transforming the pac...

November 12, 2025 | News

Boehringer Ingelheim’s Metalyse Gains Singapore Approval for Acute Ischaemic Stroke Treatment

Boehringer Ingelheim, one of the world’s leading research-driven pharmaceutical companies, has announced that the blood clot-dissolving medicine...

November 12, 2025 | News

Simcere Advances Treg-Selective IL-2 Mutant SIM0278 into Phase II Trial for Moderate-to-Severe Atopic Dermatitis

Simcere Pharmaceutical Group (2096.HK) announced that its regulatory T cells (Treg) -preferential IL-2 mutant Fc fusion protein (IL-2 mu-Fc), SIM0278,...

November 11, 2025 | News

Lumonus Raises A$25 Million Series B to Accelerate Global Adoption of Its AI-Powered Oncology Workflow Platform

Lumonus, a leader in AI powered radiation oncology workflow solutions, announced the close of its A$25 million Series B financing round. The roun...

November 10, 2025 | News

Eyexora Establishes Co-Headquarters in Singapore to Drive Global Ophthalmic Innovation

-Eyexora, a biotech company pioneering innovative therapies for ophthalmic diseases through a hub-and-spoke model, announced the establishment of its co-he...

November 07, 2025 | News

PolyActiva and RareSight Forge Strategic Partnership to Develop Sustained-Release Therapies for Rare Pediatric Retinal Diseases

Partnership Leverages PolyActiva’s PREZIA™ Drug Delivery Platform Technology and RareSight’s Expertise in Rare Diseases to Advance Nove...

November 07, 2025 | News

NEXT Oncology Expands to Japan Through Partnership with Kansai Medical University

With continued global expansion, NEXT Oncology is one of the world’s largest Phase I Cancer Trial organizations. NEXT Oncology, an Avac...

November 07, 2025 | News

Mölnlycke Establishes First Wound Care Manufacturing Site in China to Strengthen Local Production and Supply Chain Resilience

Mölnlycke® Health Care, a global leader in MedTech, headquartered in Gothenburg, Sweden, is celebrating the commencement of its new wound car...

November 06, 2025 | News

Asahi Kasei’s Nefecon Included in KDIGO 2025 Guideline for IgA Nephropathy Management

Asahi Kasei, a global provider of healthcare and pharmaceutical solutions, announced that Nefecon (marketed in the United States as TARPEYO® (budesonid...

November 06, 2025 | News

Avant Technologies and SGAustria Form Joint Venture to Pioneer Stem Cell–Based Diabetes Therapies

Avant Technologies Inc. (OTCQB: AVAI) (“Avant” or the “Company”), a Nevada-based corporation, and SGAustria Pte. Ltd. (SGAustria), ...

November 06, 2025 | News

Novo Nordisk Launches Wegovy® in Hong Kong to Tackle Rising Obesity Rates with Proven Long-Term Weight Management Therapy

Wegovy® (semaglutide) is a once-weekly injectable prescription medicine used in combination with a reduced calorie diet and increased physical a...

November 04, 2025 | News

Stay Connected